Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Posanski; Ulrich
Address:
Freiburg, DE
No. of patents:
19
Patents:












Patent Number Title Of Patent Date Issued
7511014 Cyclosporin galenic forms March 31, 2009
Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10.
7235248 Pharmaceutical compositions comprising cyclosporins June 26, 2007
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2-Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weigh
7081445 Cyclosporin galenic forms July 25, 2006
Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10.
6844459 Pharmaceutical Composition January 18, 2005
Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-, di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesteri
6503883 Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis January 7, 2003
The invention relates to a pharmaceutical preparation, which contains an immunosuppressive active agent in dissolved form in a starch capsule, or hard or soft gelatin capsule which has been coated with one or several polymer films. The invention further relates to a process for the p
6468968 Cyclosporin galenic forms October 22, 2002
Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10.
6262022 Pharmaceutical compositions containing cyclosporin as the active agent July 17, 2001
Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-, di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesteri
6258808 Pharmaceutical composition July 10, 2001
Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-,di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesterif
6204243 Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis March 20, 2001
The invention relates to a pharmaceutical preparation, which contains an immunosuppressive active agent in dissolved form in a starch capsule, or hard or soft gelatin capsule which has been coated with one or several polymer films. The invention further relates to a process for the p
6024978 Pharmaceutical compositions comprising cyclosporins February 15, 2000
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 -alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular we
6007840 Pharmaceutical compositions comprising cyclosporins December 28, 1999
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5962017 Pharmaceutical compositions comprising cyclosporins October 5, 1999
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5962014 Pharmaceutical compositions comprising cyclosporins October 5, 1999
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5916589 Pharmaceutical compositions comprising cyclosporins June 29, 1999
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5866159 Pharmaceutical compositions comprising cyclosporins February 2, 1999
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5756450 Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutic May 26, 1998
A combination of a pharmacologically active compound and a water soluble monoester of a saturated or unsaturated (C.sub.6-18) fatty acid and a polyol, especially a saccharide, particularly as a solid solution of the active compound in the monoester.The solid solution is especially suitab
5741512 Pharmaceutical compositions comprising cyclosporins April 21, 1998
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5342625 Pharmaceutical compositions comprising cyclosporins August 30, 1994
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
4567161 Liquid active ingredient concentrates for preparation of microemulsions January 28, 1986
Liquid, active substance formulations containing an active substance insoluble or poorly soluble in water, or a mixture, a phospholipid, a special co-emulsifier (glycerinester in which the 1 or 2 OH groups have been esterized with hydrocarbon atoms of 8-16, preferably 8-10, C atoms by










 
 
  Recently Added Patents
Electric motor
Method of treating cancer using a survivin inhibitor
Herbal composition for the treatment of wound healing, a regenerative medicine
Method and apparatus for complementing an instrument panel by utilizing augmented reality
Hand-held optical probe based imaging system with 3D tracking facilities
Chip on chip semiconductor device including an underfill layer having a resin containing an amine-based curing agent
Identifying conceptually related terms in search query results
  Randomly Featured Patents
Method of enabling printed interaction with computer software
Extraction of hydrocarbons from hydrocarbon-containing materials and/or processing of hydrocarbon-containing materials
Technique for preventing reflections in a cathode ray tube
Rotor aerofoil blade containment
Dispenser
Simulation switch
Protection device for an injection needle with a curved tip
Method and system for cost avoidance in virtualized computing environments
Back-pressure valve for heating installations
Media disc storage container